Search results
Horizon Therapeutics (HZNP) Q2 Earnings and Revenues Lag Estimates
Zacks via Yahoo Finance· 2 years agoHorizon Therapeutics (HZNP) delivered earnings and revenue surprises of -20.74% and 6.65%,...
Analysts Estimate Horizon Therapeutics (HZNP) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 2 years agoHorizon Therapeutics (HZNP) doesn't possess the right combination of the two key ingredients for a...
Horizon Therapeutics Third Quarter 2022 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 years agoHorizon Therapeutics (NASDAQ:HZNP) Third Quarter 2022 ResultsKey Financial Results Revenue:...
Horizon Therapeutics (HZNP) Down 9.2% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoIt has been about a month since the last earnings report for Horizon Therapeutics (HZNP). Shares...
Compared to Estimates, Horizon Therapeutics (HZNP) Q2 Earnings: A Look at Key Metrics
Zacks via Yahoo Finance· 10 months agoThe headline numbers for Horizon Therapeutics (HZNP) give insight into how the company performed in...
Some Analysts Just Cut Their Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) Estimates
Simply Wall St. via Yahoo Finance· 2 years agoOne thing we could say about the analysts on Horizon Therapeutics Public Limited Company...
Horizon Therapeutics (NASDAQ:HZNP) delivers shareholders massive 48% CAGR over 5 years, surging 3.2%...
Simply Wall St. via Yahoo Finance· 2 years agoIt hasn't been the best quarter for Horizon Therapeutics Public Limited Company (NASDAQ:HZNP)...
Why Is Horizon Therapeutics (HZNP) Down 9% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Horizon Therapeutics (HZNP). Shares have lost...
Horizon Therapeutics Public Limited Company (HZNP) Rose in Q4 on Acquisition News
Insider Monkey via Yahoo Finance· 1 year agoAristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth...
Horizon (HZNP) Dazodalibep Meets Goal in Sjogren's Syndrome Study
Zacks via Yahoo Finance· 1 year agoHorizon Therapeutics (HZNP) announces that a phase II Sjogren's syndrome study of its candidate,...